389 related articles for article (PubMed ID: 31313506)
1. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
[TBL] [Abstract][Full Text] [Related]
2. Higher CSF Levels of NLRP3 Inflammasome Is Associated With Poor Prognosis of Anti-N-methyl-D-Aspartate Receptor Encephalitis.
Peng Y; Liu B; Pei S; Zheng D; Wang Z; Ji T; Pan S; Shen HY; Wang H
Front Immunol; 2019; 10():905. PubMed ID: 31214158
[TBL] [Abstract][Full Text] [Related]
3. High Level of Soluble CD146 In Cerebrospinal Fluid Might be a Biomarker of Severity of Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Li Q; Chen J; Yin M; Zhao J; Lu F; Wang Z; Yu X; Wang S; Zheng D; Wang H
Front Immunol; 2021; 12():680424. PubMed ID: 34220828
[TBL] [Abstract][Full Text] [Related]
4. Identification of cerebrospinal fluid biomarker candidates for anti-N-methyl-D-aspartate receptor encephalitis: High-throughput proteomic investigation.
Li Y; Yang K; Zhang F; Wang J; Shen H; Liu M; Guo J; Wang J
Front Immunol; 2022; 13():971659. PubMed ID: 36389787
[TBL] [Abstract][Full Text] [Related]
5. The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis.
Ai P; Zhang X; Xie Z; Liu G; Liu X; Pan S; Wang H
Acta Neurol Scand; 2018 Feb; 137(2):277-282. PubMed ID: 29023630
[TBL] [Abstract][Full Text] [Related]
6. Cell-Free Mitochondrial DNA in the CSF: A Potential Prognostic Biomarker of Anti-NMDAR Encephalitis.
Peng Y; Zheng D; Zhang X; Pan S; Ji T; Zhang J; Shen HY; Wang HH
Front Immunol; 2019; 10():103. PubMed ID: 30792710
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum levels of the NLRP3 inflammasome are associated with the severity of anti-NMDAR encephalitis in children.
Yang J; Li Y; Luo H; Ma J; Zheng Y; Zhou L; Ding R; Meng L; Zhang X; Jiang Y; Li X; Hong S; Jiang L
Clin Chim Acta; 2023 Nov; 551():117587. PubMed ID: 37813328
[TBL] [Abstract][Full Text] [Related]
8. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
Front Immunol; 2021; 12():719432. PubMed ID: 34975832
[TBL] [Abstract][Full Text] [Related]
9. Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid.
Liba Z; Kayserova J; Elisak M; Marusic P; Nohejlova H; Hanzalova J; Komarek V; Sediva A
J Neuroinflammation; 2016 Mar; 13(1):55. PubMed ID: 26941012
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Osteopontin and Inflammation-Associated Cytokines in Patients With Anti-
Zou C; Pei S; Yan W; Lu Q; Zhong X; Chen Q; Pan S; Wang Z; Wang H; Zheng D
Front Neurol; 2020; 11():519692. PubMed ID: 33250837
[TBL] [Abstract][Full Text] [Related]
11. Elevation of YKL-40 in the CSF of Anti-NMDAR Encephalitis Patients Is Associated With Poor Prognosis.
Chen J; Ding Y; Zheng D; Wang Z; Pan S; Ji T; Shen HY; Wang H
Front Neurol; 2018; 9():727. PubMed ID: 30369903
[No Abstract] [Full Text] [Related]
12. Elevated CHI3L1 and OPN levels in patients with anti-N-methyl-d-aspartate receptor encephalitis.
Zhao J; Wang C; Zhang Y; Sun R; Wang H; Li G; Zhang J
J Neuroimmunol; 2019 Sep; 334():577005. PubMed ID: 31310926
[TBL] [Abstract][Full Text] [Related]
13. Amyloid and Tau as cerebrospinal fluid biomarkers in anti-N-Methyl-D-aspartate receptor encephalitis.
Hao Q; Gong Z; Song Y; Wang Y; Meng W; Wu W; Li Y; Zhang Y
Neurol Sci; 2024 Jul; 45(7):3399-3410. PubMed ID: 38280087
[TBL] [Abstract][Full Text] [Related]
14. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
[TBL] [Abstract][Full Text] [Related]
15. Th17 cells were recruited and accumulated in the cerebrospinal fluid and correlated with the poor prognosis of anti-NMDAR encephalitis.
Zeng C; Chen L; Chen B; Cai Y; Li P; Yan L; Zeng D
Acta Biochim Biophys Sin (Shanghai); 2018 Dec; 50(12):1266-1273. PubMed ID: 30418472
[TBL] [Abstract][Full Text] [Related]
16. Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis.
Kothur K; Wienholt L; Mohammad SS; Tantsis EM; Pillai S; Britton PN; Jones CA; Angiti RR; Barnes EH; Schlub T; Bandodkar S; Brilot F; Dale RC
PLoS One; 2016; 11(8):e0161656. PubMed ID: 27575749
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid pentraxin 3 and CD40 ligand in anti-N-menthyl-d-aspartate receptor encephalitis.
Liu B; Ai P; Zheng D; Jiang Y; Liu X; Pan S; Wang H
J Neuroimmunol; 2018 Feb; 315():40-44. PubMed ID: 29306404
[TBL] [Abstract][Full Text] [Related]
18. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis.
Wang R; Guan HZ; Ren HT; Wang W; Hong Z; Zhou D
Seizure; 2015 Jul; 29():137-42. PubMed ID: 26076857
[TBL] [Abstract][Full Text] [Related]
19. Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis.
Liu B; Xie Z; Liu G; Gu Y; Pan S; Wang H
Clin Chim Acta; 2018 May; 480():79-83. PubMed ID: 29329729
[TBL] [Abstract][Full Text] [Related]
20. Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis.
Byun JI; Lee ST; Moon J; Jung KH; Sunwoo JS; Lim JA; Kim TJ; Shin YW; Lee KJ; Jun JS; Lee HS; Lee WJ; Kim YS; Kim S; Jeon D; Park KI; Jung KY; Kim M; Chu K; Lee SK
J Neuroimmunol; 2016 Aug; 297():141-7. PubMed ID: 27397087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
